Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02963753 |
|
Recruitment Status :
Completed
First Posted : November 15, 2016
Last Update Posted : April 13, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Hyperemesis; Gravidarum, With Dehydration Gestational Diabetes |
This retrospective controlled study conducted by Obstetrics and Gynecology clinics of Kayseri Training and Research Hospital.Pregnant women who delivered at the Kayseri Education and Training Hospital of Medicine, in Turkey, between January 2010 and September 2016 were identified.This study was carried out with two groups. The study group consisted of women hospitalized for Hyperemesis gravidarum (HEG) during first trimester of their pregnancy, whereas the control group included all other women who delivered in the same period.Screening for GDM was performed twice during pregnancy. The first screening was performed during the first trimester using the random plasma glucose test with a cutoff value of 109 mg/dl. Screening for GDM was performed for all women during their first prenatal visit, regardless of the presence or absence of hyperemesis-associated symptoms.The second screening was performed during the second trimester, between 24 and 27 weeks, using a 75-g oral glucose tolerance test (OGTT), after pregnant women with HEG got rid of hyperemesis. GDM was diagnosed on the basis of the universal criteria established by the International Association of Diabetes and Pregnancy Study Group: a plasma glucose level that met or exceeded the fasting cutoff value 92 mg/dl, the first-hour cutoff value 180 mg/dl, or the second-hour cutoff value 153mg/dl.
To be considered for diagnosis of pre-gestational diabetes mellitus, women had to meet at least one of the following criteria: the fasting plasma glucose test with a cutoff value of 126 mg/dl or the random plasma glucose test with a cutoff value of 200 mg/dl or the second-hour cutoff value 153mg/dl after 75 gram OGGT (American Diabetes Association) The delivery midwifery and medical records were retrospectively evaluated. All of the patient's body mass index (BMI,calculated as weight in kilograms divided by the square of height in meters), urine ketone levels and ages were recorded separately both in the initial exam and during performing 75 gram OGTT.
| Study Type : | Observational |
| Actual Enrollment : | 560 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Retrospective |
| Official Title: | Effect of Hyperemesis Gravidarum on 75 Gram Oral Glucose Tolerance Test Screening and Gestational Diabetes Mellitus |
| Study Start Date : | January 2016 |
| Actual Primary Completion Date : | November 2016 |
| Actual Study Completion Date : | November 2016 |
| Group/Cohort |
|---|
|
hyperemesis gravidarum group
The study group consisted of women hospitalized for hyperemesis during first trimester of their pregnancy
|
|
the control group
whereas the control group included all other women who delivered in the same period.
|
- To determine serum glucose levels in both groups during 75 gram oral glucose tolerance test screening [ Time Frame: 3 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 35 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- between 18 and 35 years-old singleton pregnancies and performed 75 gram OGTT
Exclusion Criteria:
- Other causes lead to nausea and vomiting in pregnancy such as gastroenteritis, gastroparesis, hepatitis, intestinal obstruction, peptic ulcer, appendicitis, pyelonephritis, urolithiasis, ovarian torsion, diabetes mellitus, hyperthyroidism, hyperparathyroidism, migraine.
- And also patients who have risks for GDM such as body mass index > 30, history of GDM in previous pregnancy and diabetes in the family were excluded.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02963753
| Principal Investigator: | YUSUF MADENDAG | Kayseri Education and Research Hospital |
| Responsible Party: | Yusuf MADENDAG, Principal Investigator, Kayseri Education and Research Hospital |
| ClinicalTrials.gov Identifier: | NCT02963753 |
| Other Study ID Numbers: |
2017/173 |
| First Posted: | November 15, 2016 Key Record Dates |
| Last Update Posted: | April 13, 2017 |
| Last Verified: | April 2017 |
|
Hyperemesis gravidarum gestational diabetes mellitus oral glucose tolerance test |
|
Diabetes, Gestational Hyperemesis Gravidarum Dehydration Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
Pregnancy Complications Water-Electrolyte Imbalance Pathologic Processes Morning Sickness Vomiting Signs and Symptoms, Digestive |

